About: Evaluation and Management of Bacterial and Fungal Infections Occurring in Patients with a Hematological Malignancy: A 2011 Update

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evaluation and Management of Bacterial and Fungal Infections Occurring in Patients with a Hematological Malignancy: A 2011 Update Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Evaluation and Management of Bacterial and Fungal Infections Occurring in Patients with a Hematological Malignancy: A 2011 Update
Creator	Wade, James Wade, J
Source	PMC
abstract	Patients with a hematological malignancy are a heterogeneous patient population who are afflicted with diseases that range from rapidly fatal acute leukemia to indolent lymphoma or chronic leukemia. Treatment options for these patients range from observation to hematopoietic stem cell transplantation (HSCT), but all patients are more susceptible to infection. The problem of infection is dynamic with continued shifts in pathogenic organisms and microbial susceptibilities, new treatment regimens that further diminish immune function, and patients receiving treatment who are now older and frailer. The classic patterns of immunodeficiency for patients with a hematological malignancy include: periods of profound neutropenia, increased iatrogenic risks (i.e., central vascular catheters), and cellular immune suppression that affects HSCT recipients, patients with lymphoid malignancies, and those receiving treatment with corticosteroids or agents like alemtuzumab [1–4]. Recent advances in antimicrobial drug development, new technology, clinical trial results, and further clinical experience have enhanced the database on which to make infection prophylaxis and treatment decisions. However, the practicing clinician must remember that the majority of basic infection management principles for patients who are neutropenic remain unchanged.
has issue date	2012-03-08(xsd:dateTime)
bibo:doi	10.1007/978-1-4614-3764-2_52
has license	no-cc
sha1sum (hex)	f5872b1bc9ed3b8a8023654b4a7b935392b296be
schema:url	https://doi.org/10.1007/978-1-4614-3764-2_52
resource representing a document's title	Evaluation and Management of Bacterial and Fungal Infections Occurring in Patients with a Hematological Malignancy: A 2011 Update
has PubMed Central identifier	PMC7120157
schema:publication	Neoplastic Diseases of the Blood
resource representing a document's body	covid:f5872b1bc9ed3b8a8023654b4a7b935392b296be#body_text
is schema:about of	named entity 'Hematological' named entity 'Evaluation' named entity 'Fungal Infections' named entity 'Hematological Malignancy' named entity 'fever' named entity 'colony-stimulating factors' named entity 'zygomycetes' named entity 'oral medications' named entity 'antibiotic' named entity 'diagnostic tests' named entity 'respiratory syncytial virus' named entity 'coagulase' named entity 'anaerobes' named entity 'liposomal' named entity 'alimentary tract' named entity 'Pneumocystis' named entity 'neutropenic' named entity 'Aspergillus' named entity 'fever' named entity 'fever' named entity 'blood cultures' named entity 'oral mucositis' named entity 'CT scans' named entity 'daptomycin' named entity 'aspergillus' named entity 'fever' named entity 'neutropenia' named entity 'infection' named entity 'induction therapy' named entity 'randomized trial' named entity 'catheter' named entity 'HSCT' named entity 'acute leukemia' named entity 'nosocomial' named entity 'vancomycin' named entity 'antibiotics' named entity 'empiric antibiotic' named entity 'prophylaxis' named entity 'negative result' named entity 'catheter' named entity 'lumens' named entity 'oxygen saturation' named entity 'infection' named entity 'VRE' named entity 'catheter' named entity 'voriconazole' named entity 'Vancomycin' named entity 'infection' named entity 'fever' named entity 'clinical trial' named entity 'invasive aspergillosis' named entity 'prophylaxis' named entity 'transaminase' named entity 'posaconazole' named entity 'aspergillosis' named entity 'neutrophil' named entity 'fever' named entity 'antimicrobial prophylaxis' named entity 'infection' named entity 'neutropenia' named entity 'infection' named entity 'allogeneic' named entity 'infection' named entity 'bronchoalveolar lavage' named entity 'antifungal' named entity 'hematopoietic stem cell transplantation' named entity 'allogeneic' named entity 'galactomannan' named entity 'amphotericin' named entity 'neutropenic fever' named entity 'lungs' named entity 'infection' named entity 'infection' named entity 'fungal infections' named entity 'Candida spp' named entity 'graft rejection' named entity 'bloodstream infection' named entity 'conjunctivitis' named entity 'Antibiotic resistance' named entity 'fever' named entity 'voriconazole' named entity 'acute leukemia'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software